Fairvalue-Calculator Fairvalue-Calculator
EN DE

MediPharm Labs Corp (MEDIF) Fair Value & Analysis

Healthcare · US · Market cap $22.1M

Price$0.0510
Fair Value$0.0505
Upside-1.0%
Quality95/100
Evidence: Low Range $0.0403 – $0.0556

Fair value as of: Jun 26, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

MediPharm Labs Corp (MEDIF) currently trades at $0.0510, while our model-based Fair Value estimate is $0.0505 — implying the stock looks roughly 1.0% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

MediPharm Labs Corp. operates as a pharmaceutical company that produces and sells purified, pharmaceutical-like cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally. The company formulates, processes, packages, and distributes cannabis active ingredients and advanced cannabinoid-based products. It also provides good manufacturing practice flower sourcing, packaging, and distribution services, as well as dried flower, pre-roll, and other cannabis products. In addition, the company offers cannabis related medical information and services; and cannabis clinic services for patients requiring medical cannabis education and prescriptions. MediPharm Labs Corp. was founded in 2015 and is based in Barrie, Canada.

Open the full interactive analysis →

Similar stocks

Takeda Pharmaceutical Company (TAKP34) +3193% Jiangsu Hengrui Pharmaceuticals Co (600276) -37% Sun Pharmaceutical Industries Limited (SUNPHARMA) -44% Zoetis Inc (Z1TS34) -1% Hansoh Pharmaceutical Group (3692) -37% Divi's Laboratories Limited (DIVISLAB) -70%

Frequently asked questions

Is MediPharm Labs Corp (MEDIF) undervalued?
As of Jun 26, 2026, our model estimates a fair value of $0.0505 versus a price of $0.0510 — about −1% (overvalued). Model-based estimate, not financial advice.
What is the fair value of MEDIF?
Our 21-model fair value for MediPharm Labs Corp is $0.0505 (as of Jun 26, 2026), built from audited fundamentals. The current price is $0.0510.
What is the quality score of MEDIF?
MediPharm Labs Corp has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.